Hiv-1 env fragment fusion protein

Details Hiv-1 env fragment fusion protein Hiv-1 env fragment fusion protein

C - Chemistry, Metallurgy

12

N

C12N 9/38 (2006.01) A61K 39/21 (2006.01) A61K 39/42 (2006.01) A61K 47/48 (2006.01) C07K 14/16 (2006.01) C07K 16/10 (2006.01) C07K 19/00 (2006.01) C12N 9/00 (2006.01) G01N 33/569 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2071858

2071858 9109872 PCTABS00005 Highly conserved polypeptide sequences derived from gp4l and gp 120, preferably from eleven to twenty-one amino acids in length, are joined (for example, via DNA recombinant techniques) to a non-HIV protein or polypeptide sequence comprising an amino-acid sequence not naturally encoded by the HIV genome, thereby forming a fusion protein. Such fusion proteins possess attributes that make them suitable for use in the diagnosis, treatment and prevention of HIV infection.

Affiliated with

Also associated with

Rating

Hiv-1 env fragment fusion protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hiv-1 env fragment fusion protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hiv-1 env fragment fusion protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1432309